Vanguard Group’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,215,949
Closed -$75.5M 4417
2024
Q2
$75.5M Sell
2,215,949
-45,246
-2% -$1.34M ﹤0.01% 1970
2024
Q1
$79.6M Sell
2,261,195
-59,851
-3% -$2.01M ﹤0.01% 1974
2023
Q4
$67M Buy
2,321,046
+213,636
+10% +$5.09M ﹤0.01% 2066
2023
Q3
$48.3M Buy
2,107,410
+200,772
+11% +$10.5M ﹤0.01% 2152
2023
Q2
$109M Buy
1,906,638
+215,820
+13% +$11.3M ﹤0.01% 1804
2023
Q1
$63.6M Buy
1,690,818
+20,442
+1% +$753K ﹤0.01% 2056
2022
Q4
$44.7M Buy
1,670,376
+218,669
+15% +$5.98M ﹤0.01% 2239
2022
Q3
$41.1M Buy
1,451,707
+124,861
+9% +$3.48M ﹤0.01% 2277
2022
Q2
$28.8M Buy
1,326,846
+88,432
+7% +$2.47M ﹤0.01% 2465
2022
Q1
$49.7M Buy
1,238,414
+41,094
+3% +$1.72M ﹤0.01% 2308
2021
Q4
$56.7M Buy
1,197,320
+10,289
+0.9% +$552K ﹤0.01% 2279
2021
Q3
$67.2M Buy
1,187,031
+210,472
+22% +$12.7M ﹤0.01% 2205
2021
Q2
$56M Buy
976,559
+26,261
+3% +$1.44M ﹤0.01% 2310
2021
Q1
$60.1M Buy
950,298
+247,130
+35% +$11.3M ﹤0.01% 2215
2020
Q4
$23.6M Buy
703,168
+19,310
+3% +$571K ﹤0.01% 2555
2020
Q3
$18.7M Buy
683,858
+67,571
+11% +$1.77M ﹤0.01% 2490
2020
Q2
$16.7M Buy
616,287
+475,905
+339% +$8.91M ﹤0.01% 2514
2020
Q1
$2.06M Buy
140,382
+31,096
+28% +$521K ﹤0.01% 3308
2019
Q4
$1.88M Sell
109,286
-36,521
-25% -$569K ﹤0.01% 3469
2019
Q3
$2.64M Buy
145,807
+69,405
+91% +$1.45M ﹤0.01% 3358
2019
Q2
$1.51M Buy
+76,402
New +$1.44M ﹤0.01% 3554

Other funds holding MORF

Vanguard Group's MORF Position: Q3 2024 in Review

Vanguard Group sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 2,215,949 shares — an estimated $75.5M sold.

Vanguard Group first reported a position in MORF in Q2 2019 and held it in 21 quarters. The position peaked at $109M in Q2 2023. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

  • Vanguard Group reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Vanguard Group sold 2,215,949 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $75.5M.
  • Vanguard Group first reported a position in Morphic Holding, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
  • Vanguard Group's Morphic Holding, Inc. Common Stock position peaked at $109M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on Vanguard Group's 13F filing for Q3 2024, filed 13 Nov 2024.